+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insomnia Pharmacological Treatment Market by Drug, Treatment, Distribution Channel - Global Forecast 2025-2030- Product Image
Insomnia Pharmacological Treatment Market by Drug, Treatment, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Insomnia Pharmacological Treatment Market by Drug, Treatment, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5206435
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Insomnia Pharmacological Treatment Market grew from USD 6.58 billion in 2023 to USD 7.01 billion in 2024. It is expected to continue growing at a CAGR of 7.07%, reaching USD 10.62 billion by 2030.

The insomnia pharmacological treatment market encompasses a range of medications designed to alleviate symptoms of insomnia, targeting improved sleep quality and duration. This market is driven by the necessity to address the growing prevalence of sleep disorders, aged population, and heightened awareness of mental health issues, yielding various applications across healthcare settings, including hospitals, clinics, and homecare. End-users range from individuals seeking over-the-counter solutions to severe cases requiring prescription medications. Key growth factors include advancements in drug development, such as orexin receptor antagonists, and increasing research on the link between insomnia and health problems like cardiovascular diseases. Opportunities lie in developing personalized medicine targeting specific sleep disorder patterns and exploring plant-based remedies, given rising consumer preference for natural products. The market also presents scope for digital therapeutics, enhancing accessibility to treatments through innovative mobile health applications. Nevertheless, limitations such as side effects like dependency, regulatory constraints, and the paradoxical increase in wakefulness prevent full market potential. Challenges also include competition from non-pharmacological treatments like cognitive behavioral therapy for insomnia (CBT-I). Ongoing research could focus on developing non-addictive medications, understanding the genetic basis of insomnia to tailor treatments better, and improving drug safety profiles. Additionally, innovations in delivery methods, such as slow-release formulations, might enhance adherence and efficacy. The market is highly competitive, with pharmaceutical giants and emerging biotech firms constantly innovating. These dynamics suggest a need for continuous investment in R&D and strategic partnerships to mitigate competition and harness growth. Strategies such as leveraging AI for drug discovery and fostering collaborations with sleep clinics for real-world evidence could differentiate offerings. By carefully navigating regulatory landscapes and consumer preferences, stakeholders can align their innovations effectively to market demand, fostering sustainable business growth in the insomnia pharmacological treatment sector.

Understanding Market Dynamics in the Insomnia Pharmacological Treatment Market

The Insomnia Pharmacological Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of different types of sleep disorders including insomnia and parasomnias
    • Surge in work related stress level and physical disorders
    • Increasing visits to doctor regarding to insomnia owing to rising awareness among patients
  • Market Restraints
    • Side effects associated with certain OTC and prescription medication
  • Market Opportunities
    • Development of novel products through efficient R&D activities
    • Advancement in non-pharmacological therapy to improve sleep quality
  • Market Challenges
    • Individual level stigma about insomnia in some patients

Exploring Porter’s Five Forces for the Insomnia Pharmacological Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Insomnia Pharmacological Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Insomnia Pharmacological Treatment Market

External macro-environmental factors deeply influence the performance of the Insomnia Pharmacological Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Insomnia Pharmacological Treatment Market

The Insomnia Pharmacological Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Insomnia Pharmacological Treatment Market

The Insomnia Pharmacological Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Insomnia Pharmacological Treatment Market

The Insomnia Pharmacological Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insomnia Pharmacological Treatment Market, highlighting leading vendors and their innovative profiles. These include Aa Pharma Inc., Amneal Pharmaceuticals LLC, BlaQmax by Akay Natural Ingredients Private Limited, Dr. Reddy's Laboratories, Eisai Co., Ltd., Fresenius Kabi AG, Gemini Pharmaceuticals, Idorsia Pharmaceuticals Ltd., Ingenus Pharmaceuticals, Makers Nutrition, LLC, Merck & Co., Inc., Micro Labs Limited, Paratek Pharmaceuticals, Inc., Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sivem Pharmaceuticals ULC, Sleepme Inc., SMP Nutra, Sumitomo Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Tru Body Wellness, Vanda Pharmaceuticals, Vera Herbals LLC, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Insomnia Pharmacological Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Drug
    • OTC Drugs
    • OTC Sleep Aids
    • OTC Sleep Supplements
    • Prescription Drugs
  • Treatment
    • Over-the-Counter Sleep Aids
      • Antihistamines
      • Melatonin
      • Valerian Roots
    • Prescription Sleep Aids
      • Benzodiazepines
      • Melatonin Receptor Antagonists
      • Non-benzodiazepines
        • Eszopiclone
        • Zaleplon
        • Zolpidem
      • Orexin Antagonists
  • Distribution Channel
    • Drug Stores
    • E-Commerce
    • Hospital Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of different types of sleep disorders including insomnia and parasomnias
5.1.1.2. Surge in work related stress level and physical disorders
5.1.1.3. Increasing visits to doctor regarding to insomnia owing to rising awareness among patients
5.1.2. Restraints
5.1.2.1. Side effects associated with certain OTC and prescription medication
5.1.3. Opportunities
5.1.3.1. Development of novel products through efficient R&D activities
5.1.3.2. Advancement in non-pharmacological therapy to improve sleep quality
5.1.4. Challenges
5.1.4.1. Individual level stigma about insomnia in some patients
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Insomnia Pharmacological Treatment Market, by Drug
6.1. Introduction
6.2. OTC Drugs
6.3. OTC Sleep Aids
6.4. OTC Sleep Supplements
6.5. Prescription Drugs
7. Insomnia Pharmacological Treatment Market, by Treatment
7.1. Introduction
7.2. Over-the-Counter Sleep Aids
7.2.1. Antihistamines
7.2.2. Melatonin
7.2.3. Valerian Roots
7.3. Prescription Sleep Aids
7.3.1. Benzodiazepines
7.3.2. Melatonin Receptor Antagonists
7.3.3. Non-benzodiazepines
7.3.3.1. Eszopiclone
7.3.3.2. Zaleplon
7.3.3.3. Zolpidem
7.3.4. Orexin Antagonists
8. Insomnia Pharmacological Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Drug Stores
8.3. E-Commerce
8.4. Hospital Pharmacies
8.5. Retail Pharmacies
9. Americas Insomnia Pharmacological Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Insomnia Pharmacological Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Insomnia Pharmacological Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OTC SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OTC SLEEP SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 53. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 55. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 56. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 57. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 59. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 63. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 85. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 87. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 88. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 89. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 91. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 93. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 94. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 95. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 103. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 106. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 107. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 139. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 142. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 143. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 158. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 159. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 161. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 162. DENMARK INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 164. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 165. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 168. EGYPT INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 170. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 173. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 174. FINLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 176. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 180. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 182. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 185. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 186. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 194. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 196. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 197. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 198. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 212. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 215. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 216. NORWAY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 218. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 219. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 220. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 221. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 222. POLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 224. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 225. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 226. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 227. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 228. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 248. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 249. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 252. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 266. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 267. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 269. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 270. TURKEY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Insomnia Pharmacological Treatment Market, which are profiled in this report, include:
  • Aa Pharma Inc.
  • Amneal Pharmaceuticals LLC
  • BlaQmax by Akay Natural Ingredients Private Limited
  • Dr. Reddy's Laboratories
  • Eisai Co., Ltd.
  • Fresenius Kabi AG
  • Gemini Pharmaceuticals
  • Idorsia Pharmaceuticals Ltd.
  • Ingenus Pharmaceuticals
  • Makers Nutrition, LLC
  • Merck & Co., Inc.
  • Micro Labs Limited
  • Paratek Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi S.A.
  • Sivem Pharmaceuticals ULC
  • Sleepme Inc.
  • SMP Nutra
  • Sumitomo Pharma Co., Ltd.
  • Takeda Pharmaceuticals Company Ltd.
  • TriVue Pharmaceuticals, Inc.
  • Tru Body Wellness
  • Vanda Pharmaceuticals
  • Vera Herbals LLC
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.62 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Insomnia Market Report by Therapy Type, Drug Class, Distribution Channel, and Region 2024-2032 - Product Image

Insomnia Market Report by Therapy Type, Drug Class, Distribution Channel, and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Insomnia Global Market Report 2024 - Product Image

Insomnia Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Insomnia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Insomnia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 163 Pages
  • Global
Insomnia Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Insomnia Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants), By Sales Channel (Prescription, OTC), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants), By Sales Channel (Prescription, OTC), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.